Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

Alejandro Arana,1 Anton Pottegård,2 Josephina G Kuiper,3 Helen Booth,4 Johan Reutfors,5 Brian Calingaert,6 Lars Christian Lund,2 Elizabeth Crellin,4 Marcus Schmitt-Egenolf,5,7 James A Kaye,8 Karin Gembert,5 Kenneth J Rothman,8 Helle Kieler,5 Daniel Dedman,4 Eline Houben,3 Lia Gutiérrez,1 Jesper Hall...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Arana A, Pottegård A, Kuiper JG, Booth H, Reutfors J, Calingaert B, Lund LC, Crellin E, Schmitt-Egenolf M, Kaye JA, Gembert K, Rothman KJ, Kieler H, Dedman D, Houben E, Gutiérrez L, Hallas J, Perez-Gutthann S
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Dove Medical Press 2021-12-01
Seri Bilgileri:Clinical Epidemiology
Konular:
tacrolimus
pimecrolimus
cutaneous t-cell lymphoma
malignant melanoma
non-melanoma skin cancer
database study
Online Erişim:https://www.dovepress.com/long-term-risk-of-skin-cancer-and-lymphoma-in-users-of-topical-tacroli-peer-reviewed-fulltext-article-CLEP

Internet

https://www.dovepress.com/long-term-risk-of-skin-cancer-and-lymphoma-in-users-of-topical-tacroli-peer-reviewed-fulltext-article-CLEP

Benzer Materyaller